[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Gabapentin Enacarbil Market Research Report 2016-2026

January 2022 | 96 pages | ID: GC6499CB8CBFEN
HeyReport

US$ 1,930.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Gabapentin Enacarbil market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • Capsule
  • Tablet
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Arbor Pharma
  • Astellas
  • GlaxoSmithKline
  • Glenmark Pharma
  • Pfizer
  • Depomed
  • Teva
  • Mylan
  • Novartis
  • Apotex
  • Sun Pharmaceutical
  • Aurobindo Pharma
  • Intas
  • Amneal
  • Marksans Pharma
  • Alkem
  • Jiangsu Enhua
  • Jiangsu Hengrui
  • Sailike Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Post-Herpetic Neuralgia (PHN)
  • Restless Legs Syndrome (RLS)
  • Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
Figure Gabapentin Enacarbil Picture
  1.1.2 Specifications
Table Product Specifications of Gabapentin Enacarbil
1.2 Market Segment
  1.2.1 by Type
Table Products Segment of Gabapentin Enacarbil
Table Global Gabapentin Enacarbil Market by Type, 2016-2026 (USD Million)
    1.2.1.1 Capsule
Table Capsule Overview
    1.2.1.2 Tablet
Table Tablet Overview
  1.2.2 by Application
Table Application Segment of Gabapentin Enacarbil
Table Global Gabapentin Enacarbil Market by Application, 2016-2026 (USD Million)
    1.2.2.1 Post-Herpetic Neuralgia (PHN)
Table Post-Herpetic Neuralgia (PHN) Overview
    1.2.2.2 Restless Legs Syndrome (RLS)
Table Restless Legs Syndrome (RLS) Overview
    1.2.2.3 Others
Table Others Overview
  1.2.3 by Regions
Table Global Gabapentin Enacarbil Market by Region, 2016-2026 (USD Million)

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
Figure Industry Chain Structure of Gabapentin Enacarbil
2.2 Upstream
Table Cost of Gabapentin Enacarbil
Figure Manufacturing Process of Gabapentin Enacarbil
2.3 Market
  2.3.1 SWOT
Figure SWOT of Gabapentin Enacarbil
  2.3.2 Dynamics
Table Market Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
Table Policy of Gabapentin Enacarbil
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Gabapentin Enacarbil
3.4 Market Entry
Table Market Entry of Gabapentin Enacarbil

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Capsule Market, 2016-2020
Figure Capsule Market Size and Growth, 2016-2020 (USD Million)
Figure Capsule Market Size and Growth, 2016-2020 (in Volume)
Table Capsule CAGR by Revenue and Volume, 2016-2020
  4.1.2 Tablet Market, 2016-2020
Figure Tablet Market Size and Growth, 2016-2020 (USD Million)
Figure Tablet Market Size and Growth, 2016-2020 (in Volume)
Table Tablet CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
  4.2.1 Capsule Market Forecast, 2021-2026
Figure Capsule Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Capsule Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Capsule CAGR by Revenue and Volume, 2016-2026
  4.2.2 Tablet Market Forecast, 2021-2026
Figure Tablet Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Tablet Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Tablet CAGR by Revenue and Volume, 2016-2026

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Post-Herpetic Neuralgia (PHN) Market, 2016-2020
Figure Post-Herpetic Neuralgia (PHN) Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Post-Herpetic Neuralgia (PHN) CAGR by Revenue and Volume, 2016-2020
  5.1.2 Restless Legs Syndrome (RLS) Market, 2016-2020
Figure Restless Legs Syndrome (RLS) Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Restless Legs Syndrome (RLS) CAGR by Revenue and Volume, 2016-2020
  5.1.3 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
  5.2.1 Post-Herpetic Neuralgia (PHN) Market Forecast, 2021-2026
Figure Post-Herpetic Neuralgia (PHN) Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Post-Herpetic Neuralgia (PHN) Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Post-Herpetic Neuralgia (PHN) CAGR by Revenue and Volume, 2021-2026
  5.2.2 Restless Legs Syndrome (RLS) Market Forecast, 2021-2026
Figure Restless Legs Syndrome (RLS) Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Restless Legs Syndrome (RLS) Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Restless Legs Syndrome (RLS) CAGR by Revenue and Volume, 2021-2026
  5.2.3 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2021-2026

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
    6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
    6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
    6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
    6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
    6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
    6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
    6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
    6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
    6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
    6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
  6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
  6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
  6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
  6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
Table Global Gabapentin Enacarbil Market by Vendors, 2016-2020 (in Volume)
Table Global Gabapentin Enacarbil Market Share by Vendors, 2016-2020 (USD Million)
Table Global Gabapentin Enacarbil Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Gabapentin Enacarbil Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview

8 MAJOR VENDORS

8.1 Arbor Pharma
Table Arbor Pharma Profile List
Table Microecological Modulator Operating Data of Arbor Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Astellas
Table Astellas Profile List
Table Microecological Modulator Operating Data of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 GlaxoSmithKline
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Glenmark Pharma
Table Glenmark Pharma Profile List
Table Microecological Modulator Operating Data of Glenmark Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Depomed
Table Depomed Profile List
Table Microecological Modulator Operating Data of Depomed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Teva
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Mylan
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Apotex
Table Apotex Profile List
Table Microecological Modulator Operating Data of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Sun Pharmaceutical
Table Sun Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Aurobindo Pharma
Table Aurobindo Pharma Profile List
Table Microecological Modulator Operating Data of Aurobindo Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Intas
Table Intas Profile List
Table Microecological Modulator Operating Data of Intas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Amneal
Table Amneal Profile List
Table Microecological Modulator Operating Data of Amneal (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Marksans Pharma
Table Marksans Pharma Profile List
Table Microecological Modulator Operating Data of Marksans Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Alkem
Table Alkem Profile List
Table Microecological Modulator Operating Data of Alkem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Jiangsu Enhua
Table Jiangsu Enhua Profile List
Table Microecological Modulator Operating Data of Jiangsu Enhua (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 Jiangsu Hengrui
Table Jiangsu Hengrui Profile List
Table Microecological Modulator Operating Data of Jiangsu Hengrui (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.19 Sailike Pharma
Table Sailike Pharma Profile List
Table Microecological Modulator Operating Data of Sailike Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Gabapentin Enacarbil
Table Products Segment of Gabapentin Enacarbil
Table Global Gabapentin Enacarbil Market by Type, 2016-2026 (USD Million)
Table Capsule Overview
Table Tablet Overview
Table Application Segment of Gabapentin Enacarbil
Table Global Gabapentin Enacarbil Market by Application, 2016-2026 (USD Million)
Table Post-Herpetic Neuralgia (PHN) Overview
Table Restless Legs Syndrome (RLS) Overview
Table Others Overview
Table Global Gabapentin Enacarbil Market by Region, 2016-2026 (USD Million)
Table Cost of Gabapentin Enacarbil
Table Market Dynamics
Table Policy of Gabapentin Enacarbil
Table GDP of Major Countries
Table Technology of Gabapentin Enacarbil
Table Market Entry of Gabapentin Enacarbil
Table Capsule CAGR by Revenue and Volume, 2016-2020
Table Tablet CAGR by Revenue and Volume, 2016-2020
Table Capsule CAGR by Revenue and Volume, 2016-2026
Table Tablet CAGR by Revenue and Volume, 2016-2026
Table Post-Herpetic Neuralgia (PHN) CAGR by Revenue and Volume, 2016-2020
Table Restless Legs Syndrome (RLS) CAGR by Revenue and Volume, 2016-2020
Table Others CAGR by Revenue and Volume, 2016-2020
Table Post-Herpetic Neuralgia (PHN) CAGR by Revenue and Volume, 2021-2026
Table Restless Legs Syndrome (RLS) CAGR by Revenue and Volume, 2021-2026
Table Others CAGR by Revenue and Volume, 2021-2026
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
Table North America CAGR by Revenue and Volume, 2016-2020
Table Europe CAGR by Revenue and Volume, 2016-2020
Table South America CAGR by Revenue and Volume, 2016-2020
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
Table North America CAGR by Revenue and Volume, 2021-2026
Table Europe CAGR by Revenue and Volume, 2021-2026
Table South America CAGR by Revenue and Volume, 2021-2026
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
Table Global Gabapentin Enacarbil Market by Vendors, 2016-2020 (in Volume)
Table Global Gabapentin Enacarbil Market Share by Vendors, 2016-2020 (USD Million)
Table Global Gabapentin Enacarbil Market Share by Vendors, 2016-2020 (in Volume)
Table Price Factors List
Table Arbor Pharma Profile List
Table Microecological Modulator Operating Data of Arbor Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Profile List
Table Microecological Modulator Operating Data of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glenmark Pharma Profile List
Table Microecological Modulator Operating Data of Glenmark Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Depomed Profile List
Table Microecological Modulator Operating Data of Depomed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Profile List
Table Microecological Modulator Operating Data of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aurobindo Pharma Profile List
Table Microecological Modulator Operating Data of Aurobindo Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Profile List
Table Microecological Modulator Operating Data of Intas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amneal Profile List
Table Microecological Modulator Operating Data of Amneal (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Marksans Pharma Profile List
Table Microecological Modulator Operating Data of Marksans Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alkem Profile List
Table Microecological Modulator Operating Data of Alkem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jiangsu Enhua Profile List
Table Microecological Modulator Operating Data of Jiangsu Enhua (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jiangsu Hengrui Profile List
Table Microecological Modulator Operating Data of Jiangsu Hengrui (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sailike Pharma Profile List
Table Microecological Modulator Operating Data of Sailike Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)


LIST OF FIGURES

Figure Gabapentin Enacarbil Picture
Figure Industry Chain Structure of Gabapentin Enacarbil
Figure Manufacturing Process of Gabapentin Enacarbil
Figure SWOT of Gabapentin Enacarbil
Figure Capsule Market Size and Growth, 2016-2020 (USD Million)
Figure Capsule Market Size and Growth, 2016-2020 (in Volume)
Figure Tablet Market Size and Growth, 2016-2020 (USD Million)
Figure Tablet Market Size and Growth, 2016-2020 (in Volume)
Figure Capsule Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Capsule Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Tablet Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Tablet Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Post-Herpetic Neuralgia (PHN) Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Figure Restless Legs Syndrome (RLS) Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Figure Post-Herpetic Neuralgia (PHN) Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Post-Herpetic Neuralgia (PHN) Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Restless Legs Syndrome (RLS) Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Restless Legs Syndrome (RLS) Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Gabapentin Enacarbil Market Concentration by Region
Figure Marketing Channels Overview


More Publications